PGR and breast cancer: BC could be classified as hormone-positive (estrogen receptor, ER+, and progesterone receptor, PR+), human epidermal receptor-2-positive (HER2+), and triple-negative BC (TNBC) (ER−, PR−, HER2−) [2,3].